Seminars in Hematology

Papers
(The H4-Index of Seminars in Hematology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
CAR T-cell therapy comes of age: Introductory editorial for the special issue62
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial58
Extramedullary myeloma in the era of CAR T-cell and bispecific antibody therapies52
Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation50
Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?46
Clinical applications of circulating tumor DNA in Hodgkin lymphoma44
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-1943
How to set up a clinical research center in Brazil, as an example of a middle-income country41
Epidemiology and etiology of diffuse large B-cell lymphoma39
Somatic mutations in “benign” blood diseases37
TET2 mutation as prototypic clonal hematopoiesis lesion37
The future of lymphoma diagnosis, prognosis, and treatment monitoring in countries with limited access to pathology services34
Antibody and immunotherapy in diffuse large B-cell lymphoma30
Lessons learned from the Eµ-TCL1 mouse model of CLL27
Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence26
The role of viruses in HIV-associated lymphomas24
Vaccinations in patients with chronic lymphocytic leukemia22
Intestinal microbiome and myelodysplastic syndromes: Current state of knowledge and perspectives for future21
The molecular map of CLL and Richter's syndrome19
0.076124906539917